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Summary. In this article it was made an analysis of the case history out-patient medical records of 30 patients with synchronic bilateral breast 
cancer (SBBC), 34 patients with unilateral breast cancer (BC) and 32 healthy patients. The obtained results show the higher mammographic density in 
patients having the synchronic BBC in comparison with the healthy patients and lesser density compared with the unilateral BC. The 2nd grade of the 
mammographic density is 60% in the group of the synchronic BBC and is higher on 34-35% than that of the two other groups. The presence of the 2nd 
grade of the mammographic density of the mammary gland requests the more thorough examination (Ultrasonic examination, MRT) for excluding the 
synchronic BBC.
Key words: synchronic bilateral breast cancer, mammographic density.
Резюме. В статті проведено порівнювальний аналіз даних мамографічної щільності в 30 пацієнток із синхронним 
двостороннім раком молочної залози (ДРМЗ), 34 пацієнток з одностороннім раком молочної залози (РМЗ) та 32 здо-
рових жінок. Отримані результати виявили більший ступінь мамографічної щільності у жінок із синхронним ДРМЗ в 
порівнянні з здоровими пацієнтками і в незначній мірі в порівнянні з хворими на односторонній РМЗ. Другий ступінь 
мамографічної щільності становить 60% в групі з синхронним ДРМЗ, що на 34-35% більше в порівнянні з обома 
іншими групами. Наявність 2 ступеня мамографічної щільності молочної залози вимагає більш уважного обстеження 
(УЗД, МРТ) для виключення наявності синхронного ДРМЗ.
Ключові слова: синхронній двосторонній рак молочної залози, мамографічна щільність.
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 Synchronic bilateral breast cancer (SBBC) and metachronous 
bilateral breast cancer appear in 10-20% of cases. The relevance 
of the its forms is made up of the fact that in the prognostic sense 
the bilateral breast cancer has more aggressive disease course 
compared with the unilateral process. The essentially aggressive 
course has been established in the cases when the pathology is 
developing under 40 years of age and the interval between the 
primary and secondary tumors is very short – up to 1-3 years. The 
disease course is more aggressive for the SBBC in contrast with 
the metachronous one. 
Concerning the problem of bilateral breast cancer (BBC) diag-
nostics, the special significance is devoted to the early secondary 
tumor detection, which has an effect on the disease prognosis. 
The early metachronous BBC diagnostics is a crucial point for this 
sphere. About a half of the bilateral breast cancer cases are heredi-
tarily determined, thus, the specification of the BRCA1 and BRCA2 
genes mutation could be an alternative variant of the preliminary 
diagnostics. But, therethrough, there could not be covered all the 
cases.
A substantial point is the identification of such patients for the 
early detection of the secondary tumors in another breast. There are 
papers which show that the greater risk of the BBC development was 
specified in patients with the body weight more than 60 kg (three 
times as much as other); more typical was the development of BBC 
in patients with the blood group AB(IV) and positive progesterone re-
ceptors in the tumor [1]. It is possible to prognosticate that the tumor’s 
multicentric growth in one mammary gland suggests a tendency to 
the metachronous process beginning in the contralateral breast. Inso-
far as the basic method of the breast cancer (BC) diagnostics is the 
mammography. It is important to screen the secondary breast too, i.e. 
to diagnose BC on the preclinical phase. 
Now is known, that the high tissues’ mammographic density 
(TMD) is associated with the BC development risk increasing by 1,8 
– 6 times [2, 3, 4], and besides, among all risk factors, in spite of the
large body of research, it is the less studied one [5]. It has never been 
resolved the open question of the mammographic diagnostic method 
sensitivity and specificity decreasing while diagnosticating the women 
with high TMD, the problem of so-called interval cancer [6, 7, 8]. 
TMD is defined as the proportion of radiodense fibroglandular tis-
sue in the breast [9]. The two component parts of the breast tissue– 
fibroglandular tissue and fat- look in a different way. The fat has the 
lower X-rays transmission coefficient, thus, some parts of the fatty 
tissue look darker on the shadow gram. The lighter parts, represented 
by the fibroglandular tissue, specify the mammographic density [2]. 
The significant role in the TMD visualization plays the stroma. The 
histological research of the dreast tissues with higher TMD, compared 
with the lower one, on postmenopausal women, had revealed no es-
sential difference in quantity of the lobular and ductal elements, but 
determined the higher collagen content, fibrosis dissemination and 
the expression of two stromal proteoglycans – the lumican and deco-
rin, etc. The latest one correlates with the BC development [10, 11]. 
The collagen and stroma due to their mechanical properties promote 
the tumor invasion [12]. 
The reduction of the collagen and granulation tissue as well as 
fatty tissue growing with the increase of years – involution – are asso-
ciated with the BC. In the majority of carcinoma cases (breast cancer 
in particular) the adhesive capacity of the stromal E-cadherins are es-
sentially decreased and this leads to the disturbance of the cell junc-
tions and facilitates the release of cells from the primary tumoral lump 
[3]. It is proved that the reattachment of the tumoral cells to the lam-
inin and fibronectin mediated by receptors indicates the subsequent 
invasion and metastatic procedures. Moreover, tamoxifen effect could 
be predicted via the changes in the mammary gland tissue density, 
which happened to be the only statistically significant prognostic risk 
factor. At decreasing the density of the mammary gland tissue by 
10%, the risk of the BC development decreases by 52% [15]. 
In all age categories the TMD is higher in women who have the 
developed BC [12]. Whereas, the higher the BC development risk is 
at the increased TMD, the higher the TMD should be in patients with 
SBBC. 
The object of the research was to determine the mammographic 
density in patients with SBBC and compare it with the density in pa-
tients with unilateral BC. 
Materials and methods. An analysis of the case history out-patient 
medical records of 30 patients with SBBC, 34 patients with unilateral 
BC and 32 patients without any oncopathology was made. Before 
starting the special treatment the patients’ mammograms were se-
lected in the mammographic room of Kiev municipal oncology hospi-
tal. The mammograms that had been passed the neoadjuvant therapy 
– the hormonotherapy, chemotherapy and radiotherapy - were not
evaluated. The conducting of the special treatment methods, accord-
ing to the data from the literature, leads to the decrease of the mam-
mographic density, which could testify for the treatment effectiveness. 
The chosen mammograms were evaluated using the planimetric 
analysis and the level of the mammographic density was defined. The 
content of the method was in the fact that the mammograms were 
inspected through the transparent net with the cell area of 1cm². It 
was calculated the relative area in per cent of the gland tissue den-
sity to the total area of the mammary gland. The classifications Wolfe 
and BI-RADS belong to the qualitative method. BI-RADS represents 
the standardized visual classification of the mammographic findings, 
which was designed by the American Radiology College. According to 
this classification there are 4 density categories: 
Category 1 – almost completely fat tissue structure (dense struc-
tures occupy <25% of the gland area); 
Category 2 – separate fibroglandular densities (dense structures 
occupy 25% -50% of the gland area);  
Category 3 – heterogeneous density (dense structures occupy 
51% -75% of the gland area);  
Category 4 – expressed density (dense structures occupy >75% 
of the gland area).
Whereupon, the Categories 1 and 2 are defined as the low mam-
mographic tissue density, and the Categories 3 and 4 – are the high 
mammographic tissue density. 
The quantitative methods are based on the measurement of the 
dense structure area ratio to the whole mammary gland tissue area 
on the mammogram. To the quantitative methods are referred the fol-
lowing: the planimetry, the computer method and the visual classifi-
cation. The result is represented on a percentage base or the total 
density area (pixels, square centimeters or millimeters) [8, 16]. 
The mammographic density was evaluated in patients with the 
synchronic BBC and was compared to the density in patients having 
the unilateral BC and with practically healthy patients. 
Results and discussion. The average age of the patients with the 
SBBC was 63,47±12,5 years, in patients with unilateral BC it was 
58,67±9 years, and in the healthy women group – the control group 
– 60,06±7,3 years. Thus, according to the age all the patient groups
not differed from each other, which could testify for the opportunity 
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to conduct the mammographic density evaluation results comparison.
The obtained results show that the presence of BC manifests by 
increasing of the mammographic density, compared with the healthy 
women. The SBBC from its part manifests with the higher percentage 
level of the increased mammographic density in comparison with the 
healthy patients and that of having the unilateral BC. 
The Table 1 shows that in the group of patients having the 
SBBC it was detected the lowest quantity of women with the low 
mammographic density – 6(20%) which is lesser by 24% than that 
of the group with the unilateral BC and by 40% lesser than that 
of the healthy patients group. The second level of the mammo-
graphic density was significantly manifested too in the group of 
patients with SBBC. In this group the quantity of patients having the 
2nd grade of the mammographic density was 18 (60%) persons, 
which is on 34% higher than that of the group of patients having 
the unilateral BC and on 35% higher than in the healthy group. 
The 2nd grade of the mammographic density is characterized by 
fibroglandular density by 25-50% of the gland tissue area. In other 
words, the SBBC peculiarity is, in 60% of cases, the presence of 
the densed image on the mammogram, which shows the specificity 
of this disease. 
Considering the frequency of the 3d grade of the mammograph-
ic density manifestation it was detected that the group of unilateral 
BC had the major quantity of the patients – 7(21%), and it was 
on 8% fewer patients having the SBBC - 4(13%), and the lowest 
quantity was noted in the group of practically healthy women – 6%. 
The 4th grade of the mammographic density was manifested 
practically in all the groups of patients: in the group of the SBBC 
it worked out 2(7%) of women, in the group of unilateral BC it 
was 3(9%) and in the group of healthy patients it was 3(9%). In 
other words, it was no significant difference between the groups, 
although it seemed more logical that there should be more such 
cases among the patients with the SBBC. 
Mammographic 
density
Average
age 1 2 3 4
Quantity of patients 
having the SBBC 
n=30, 31% 
63,47 ±12.5 6(20%) 18(60%) 4(13%) 2(7%)
Quantity of patients 
having the unilateral 
BC n=34, 36%
58,67±9,0 15(44%) 9(26%) 7(21%) 3(9%)
Quantity of the 
healthy patients n=32, 
33%
60,06±7,3 19(60%) 8(25%) 2(6%) 3(9%)
Table 1 
The data of the mammographic density in the investigated groups
Picture 1. 
The graphs of the mammographic density in the investigated groups
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  The quantity of patients having the synchronic BC, n=30, 31%
  The quantity of patients having the unilateral BC, n-34, 36%
  The quantity of healthy patients, n=32, 33%
It is shown graphically the differences between the graphs of each 
group mammographic density grade. It is shown clearly that in the 
group of patients with the SBBC there are more cases of the increased 
mammographic density of 2nd grade and there are insignificant dif-
ferences in the cases of 3d and 4th grades of the mammary glands 
density. The low grade of the mammographic density, comparing with 
the both groups, occurs very rarely, in other words it is not practically 
typical for this group of patients. The 2nd grade of the mammographic 
density was low both in the control group and in the group of patients 
having the unilateral BC. 
The calculation of the mean grade of the mammographic density 
showed that it was 2,1 in the group of SBBC, 1,9 in the group of uni-
lateral BC and 1,6 in the group of the healthy patients, healthy as of 
the time of examining. 
The investigation that had been conducted by us showed the 
presence of the significant mammographic density profile changes in 
patients having the SBBC and healthy patients and lesser changes in 
the group of unilateral BC. The main specificity of this patient group 
was the high percentage level (60%) of the 2nd grade of the mam-
mographic density. The 3d and 4th grades were less manifested and 
did not differ statistically in all the groups. Thus, the presence of the 
2nd grade of the mammographic density at the primary diagnostics of 
the BC specifies the necessity for conducting the additional investiga-
tion methods - ultrasonic diagnosis, MRT-mammography, - to exclude 
the possibility of the SBBC or for the early diagnostics of the meta-
chronous BBC. Today, there are more and more uses of the MRT-
mammography, especially for excluding the multicentric or multifocal 
process, which predicts the disease recurrence at the planning of the 
organ preserving surgeries, and reduces the quantity of the re-surger-
ies that are consequence of the incorrectly conducted nonoperative 
interventions. For the estimation the confidence of this hypothesis it is 
necessary to conduct the investigation of the mammographic density 
in patients having the metachronous BBC and increase the quantity 
of the supervisions in patients having the SBBC.  
Conclusion. We found out that the grade of the mammographic 
density in patients with the SBBC is higher, compared with the healthy 
patients, and is lesser in comparison with the patients with the uni-
lateral BC. The most abundant grade is the 2nd grade of the mam-
mographic density in patients having the SBBC and works out 60%. 
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